Literature DB >> 11267168

Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.

F Vincenti1, A Monaco, J Grinyo, M Kinkhabwala, J Neylan, A Roza, K Somberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267168     DOI： 10.1016/s0041-1345(00)02308-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Authors:  C J Dunn; A J Wagstaff; C M Perry; G L Plosker; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.

Authors:  Arthur J Matas; Raja Kandaswamy; Abhinav Humar; William D Payne; David L Dunn; John S Najarian; Rainer W G Gruessner; Kristen J Gillingham; Lois E McHugh; David E R Sutherland
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

Review 3.  Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.

Authors:  Titte R Srinivas; Herwig-Ulf Meier-Kriesche
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

4.  Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation.

Authors:  Junichiro Sageshima; Gaetano Ciancio; Linda Chen; George W Burke
Journal:  Biologics       Date:  2009-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.